Italy: A new review published in Minerva Medica has revealed that GLP-1 receptor agonists may help preserve kidney function ...

Renalytix's kidneyintelX.dkd will be the first test offered in Tempus' portfolio in the chronic kidney disease category, indicated for use as an aid in predicting level of risk (high, moderate, low) ...

The kidneys are vital organs that play a significant role in maintaining the body’s internal environment. They filter about 200 quarts of blood daily, removing waste products and excess fluids through ...

People with Type 2 diabetes should be concerned with their kidney function, but current testing is woefully insufficient. A ...

In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...

Ozempic is the brand name of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist drug. It is commonly used to ...

With more than 25 years of clinical leadership, we’ve developed a connected ecosystem that brings together diabetes ...

Semaglutide significantly lowered the rate of complications in individuals with diabetes and chronic kidney disease. People on semaglutide saw an 18 percent drop in their risk of cardiovascular ...

Please provide your email address to receive an email when new articles are posted on . KidneyIntelX is a prognostic test that incorporates machine learning and predictive biomarkers. Clinical ...

A new study by the University of California, Davis, shows how cells work together to avoid a sudden drop in blood sugar.